BNP Paribas Financial Markets’s Vor Biopharma VOR Stock Holding History

BNP Paribas Financial Markets’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$197K	Buy	10,708 +7,864	+277%	+$119K	﹤0.01%	4244
2026 Q1	$50.7K	Buy	2,844 +2,553	+877%	+$36K	﹤0.01%	4686
2025 Q4	$3.81K	Sell	291 -5,784	-95%	-$108K	﹤0.01%	5288
2025 Q3	$296K	Buy	6,075 +6,024	+11,812%	+$242K	﹤0.01%	3815
2025 Q2	$1.65K	Hold	51	–	–	﹤0.01%	5092
2025 Q1	$730	Sell	51 -6	-11%	-$144	﹤0.01%	5104
2024 Q4	$1.27K	Buy	+57	New	+$945	﹤0.01%	5057

Other funds holding VOR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Axiom Investors Greenwich, Connecticut $11.6B AUM 69.67% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets's VOR Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Vor Biopharma (VOR) stake by 277% in Q2 2026, buying an estimated $119K and bringing the position to 10,708 shares worth $197K. The position accounts for ﹤0.01% of the portfolio, ranked #4244.

BNP Paribas Financial Markets first reported a position in VOR in Q4 2024 and has held it in 7 quarters since. The position peaked at $296K in Q3 2025. 42 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

BNP Paribas Financial Markets held 10,708 shares of Vor Biopharma worth $197K as of Q2 2026.
BNP Paribas Financial Markets bought 7,864 Vor Biopharma shares in Q2 2026, an estimated $119K.
Vor Biopharma made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4244 holding.
BNP Paribas Financial Markets first reported a position in Vor Biopharma in Q4 2024 and has held it in 7 quarters since.
BNP Paribas Financial Markets's Vor Biopharma position peaked at $296K in Q3 2025.
42 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.